Home/Protocols/LIPO-C
Protocol Reference
FAT LOSS

LIPO-C

Once to twice weekly intramuscular protocol for metabolic and weight-management research.

LIPO-C is a compounded lipotropic blend, typically methionine, inositol and choline with B12, given intramuscularly to support fat metabolism alongside a deficit. Formulations vary by compounder, so the label on your vial wins. The protocol below reflects the common weekly-to-twice-weekly IM cadence.

Quick answer: LIPO-C is typically run at 1 mL IM, once to twice weekly intramuscular, as a pre-mixed solution.

Get LIPO-C → code PEPDOSE

Category
GLP-1 & Metabolic
Common vials
100 mg total
Half-life
Varies by component
Route in the literature
Intramuscular or subcutaneous

Protocol overview

Goal
A compounded combination of lipotropic agents — commonly methionine, inositol and choline, sometimes with B-vitamins....
Schedule
Once to twice weekly intramuscular, 8-12 weeks
Format
Pre-mixed solution; no reconstitution needed
Storage
Lyophilized: frozen or 2-8 °C; reconstituted: refrigerated, use within 28 days
Evidence
There is no meaningful published dosing literature for this compound in humans.

Dosing & reconstitution

Community-reported ranges. These are the amounts commonly reported in user communities and vendor protocols, not from controlled human trials. They are listed here because they are what most people reference in practice.

Frequency: Once to twice weekly intramuscular
Typical duration: 8-12 weeks

This compound typically ships as a pre-mixed solution and does not require reconstitution.

PhaseDoseUnits per injection
Weeks 1-121 mL IM1 mL of pre-mixed lipotropic solution

Units = (dose ÷ concentration) × 100 on a U-100 syringe. Change the vial size or water volume and the calculator redoes all of this for you.

Track this protocol → Free account · log doses, rotate sites, never lose your history

LIPO-C dosing — what the literature actually supports

No dosing literature. LIPO-C is not a standardised product. Different compounders use different agents at different ratios, so there is no single formulation to study and no controlled trial establishing a schedule for "LIPO-C" as such. A schedule for one compounder’s mix would not describe another’s — read your own vial label.

We publish a schedule when there is a citable human source and we say so when there is not. Filling this space with a number nobody measured would make the page look more complete and be worth less than nothing to you.

Reconstitution and measurement

This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for LIPO-C: 100 mg total.

  1. Wipe the stoppers of both vials with an alcohol swab and let them dry.
  2. Draw the bacteriostatic water with a sterile syringe and inject it slowly down the inside wall of the peptide vial — never straight onto the powder.
  3. Swirl gently until the solution is clear. Do not shake; foaming and agitation damage peptides.
  4. Label the vial with the date and concentration, and refrigerate at 2–8 °C protected from light.

Worked example at the calculator defaults: 100 mg + 5 mL of bacteriostatic water = 20 mg/mL, so on a U-100 insulin syringe 1 unit = 200 mcg of LIPO-C. Change either input and the calculator redoes this for you.

Open the LIPO-C calculator → Unit converter

Storage and stability

Dry powder
Cold, dark and dry. Lyophilized peptide is the stable form — keep it that way until you intend to use it.
After reconstitution
Refrigerate at 2–8 °C, protect from light, and plan around a limited window. Do not freeze a reconstituted vial — freeze-thaw damages peptides.
Mixing
Run bacteriostatic water down the inside wall of the vial rather than onto the powder, then swirl. Never shake.
Inspect before use
A clear solution is expected. Cloudiness or particles mean discard, not use.

Full storage guide → · Cloudy solution?

Supplies math

Whatever amounts your research uses, the planning arithmetic is the same. The calculator runs all of this per compound.

Vials
Doses per vial = vial size in mg divided by your per-dose amount in mg. The calculator on this page runs that arithmetic for any vial size and amount you enter.
Syringes
One sterile U-100 insulin syringe per injection, plus roughly 10% spares for bent tips and mis-draws. Daily protocols run 30 or 31 per month.
Bacteriostatic water
1 to 3 mL per vial reconstituted. A single 10 mL bottle covers 3 to 10 vials, so one bottle usually outlasts several vials.
Alcohol swabs
Two per injection: one for the vial stopper, one for the site. A 100-count box covers about 7 weeks of daily work.

Important notes

Practical considerations for consistency and safety.

  • Use a new sterile insulin syringe for each injection and dispose in a proper sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) systematically to reduce local irritation and avoid lipohypertrophy.
  • Rotate intramuscular injection sites (deltoid, vastus lateralis, gluteus medius) and use the appropriate needle gauge for the muscle.
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle to ensure complete delivery.
  • Administer on the same day each week for consistency. If a dose is missed, administer as soon as possible within a few days.
  • This compound lacks controlled human safety data. Start with the lowest reported amount and increase gradually while monitoring for any adverse reactions.

How LIPO-C works

A compounded combination of lipotropic agents — commonly methionine, inositol and choline, sometimes with B-vitamins. It is a formulation category rather than a single defined compound.

Benefits & side effects

Potential benefits

  • Combined lipotropic agents in one injection
  • Supports methyl donation and liver function
  • B-vitamin components support energy metabolism
  • Convenient pre-mixed formulation

Possible side effects

  • Injection site discomfort common with IM
  • Varies by formulation and compounder
  • Occasional GI effects
  • No controlled efficacy evidence

This list reflects published literature and community reports. Individual responses vary. Not medical advice.

Bloodwork worth tracking

The community-standard practice is a baseline panel before starting, a recheck 8 to 12 weeks in, and another after time off. For LIPO-C, the markers most worth watching:

CMPCBClipid panel

Typical time off: No fixed time off

Lab panels are how a research protocol stays honest: numbers move before symptoms do. Interpretation belongs with a clinician. Not medical advice.

Lifestyle factors

None of the literature above was run on a background of poor sleep and no protein. These variables move outcomes more reliably than any compound on this site.

  • Protein in the 1.6 to 2.2 g/kg range preserves lean mass through any body-composition phase.
  • Resistance training 2 to 4 days per week plus 150+ minutes of weekly aerobic work reinforces whatever the protocol is doing.
  • Sleep is the recovery window: 7 to 9 hours at consistent times.
  • Hydration matters more than usual on compounds with GI or flushing effects: 2 to 3 liters daily.
  • Track the variables that matter: weigh-ins, measurements, photos, and labs at sensible intervals.

Subcutaneous technique and practical notes

General best practice from clinical injection guidance — the same fundamentals nurses are taught, none of it specific to any compound.

Fresh sterile syringe, every time
Reusing needles dulls the tip, hurts more, and is the easiest contamination route. Dispose of used syringes in a sharps container, not the bin.
Rotate sites
Abdomen (5 cm clear of the navel), thighs, upper arms. Rotating systematically prevents localised irritation and lipohypertrophy.
Slow and steady
Pinch a skinfold, insert at 45–90°, inject slowly, and wait a few seconds before withdrawing. Subcutaneous injections are not aspirated.
Write it down
Log the date, amount and site. A record is the only way to keep any research protocol consistent — and the first thing to review if anything looks off.

Quick answers

Does LIPO-C have human trial data?

No published dosing literature exists for LIPO-C. The amounts shown are community convention only.

How does LIPO-C work?

A compounded combination of lipotropic agents — commonly methionine, inositol and choline, sometimes with B-vitamins. It is a formulation category rather than a single defined compound.

Sourcing LIPO-C

Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.

LIPO-C at Summit Research Supply → Grade a COA first

Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.

For laboratory research use only. This page documents what the published literature reports about LIPO-C. It is not a recommendation, not a treatment plan, and not medical advice. Compounds referenced are sold strictly as research chemicals and are not for human or veterinary use. Some supplier links are affiliate links and may earn us a commission. This never affects tier placement or review conclusions.
Summit Research Supply
Summit Research Supply — COA-verified research peptidesThird-party tested · U.S. fulfillment · new researchers save 10%
Shop →